Gerris J, Vandekerckhove F, De Sutter P
Women's Clinic, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.
Facts Views Vis Obgyn. 2016 Sep;8(3):141-146.
cohort study describing clinical and laboratory outcomes in ICSI patients using self-operated endovaginal tele-monitoring (SOET).
University department of reproductive medicine.
78 patients undergoing 100 consecutive ICSI attempts.
patients' recorded vaginal sonograms and sent recordings using the cloud based Sonaura device to the care provider who procured responses, avoiding hospital visits.
Number of cycles without hospital visit, laboratory and clinical variables, transportation avoided.
In 100 attempts, only one patient missed her follicles, 9 hospital visits occurred for circumstantial reasons and 90 attempts were completed without any hospital visit between initiation and puncture. Mean number ± 2SD was for oocytes 11.7±6.6, metaphase-II oocytes 8.5±5.4, 2PN zygotes 5.5±3.7, good day-5 blastocysts 2.4±2.4, embryos transferred 1.0±0.7 and embryos frozen 1.3±2.2. Percentages of total (+HCG), clinical (cardiac activity) and on-going pregnancies (>20 weeks) were 40%, 35% and 29% per started cycle and 48.8%, 42.7% and 35.4% per embryo transfer.
Using SOET, 90% of ICSI (and IVF) patients can avoid visits to care providers for making sonograms. Results were similar as in patients with a similar profile using traditional monitoring. In appropriate patients, SOET is an efficient, safe and patient-friendly alternative for ovarian stimulation monitoring in IVF/ICSI programmes.
队列研究描述使用自行操作的阴道内远程监测(SOET)的ICSI患者的临床和实验室结果。
大学生殖医学系。
78例患者连续进行100次ICSI尝试。
患者记录阴道超声图,并使用基于云的Sonaura设备将记录发送给护理提供者,护理提供者获取反馈,避免患者前往医院就诊。
无需前往医院就诊的周期数、实验室和临床变量、避免的交通出行。
在100次尝试中,只有1例患者卵泡监测失败,9次因特殊情况前往医院就诊,90次尝试在启动至穿刺期间无需任何医院就诊即完成。卵母细胞平均数量±2标准差为11.7±6.6,中期II卵母细胞为8.5±5.4,2PN受精卵为5.5±3.7,优质第5天囊胚为2.4±2.4,移植胚胎为1.0±0.7,冷冻胚胎为1.3±2.2。每个启动周期的总妊娠(+HCG)、临床妊娠(有心脏活动)和持续妊娠(>20周)百分比分别为40%、35%和29%,每个胚胎移植的百分比分别为48.8%、42.7%和35.4%。
使用SOET,90%的ICSI(和IVF)患者可以避免前往护理提供者处进行超声检查。结果与使用传统监测的类似患者相似。对于合适的患者,SOET是IVF/ICSI计划中卵巢刺激监测的一种高效、安全且对患者友好的替代方法。